137 related articles for article (PubMed ID: 36620716)
1. Rituximab Monotherapy versus Rituximab and Bortezomib Combination Therapy for Treatment of Non-paraneoplastic Autoimmune Retinopathy.
Maleki A; Colombo A; Look-Why S; Peter Y Chang BA; Anesi SD; Anesi SD
J Ophthalmic Vis Res; 2022; 17(4):515-528. PubMed ID: 36620716
[TBL] [Abstract][Full Text] [Related]
2. Combination Treatment with Rituximab and Bortezomib in a Patient with Non-Paraneoplastic Autoimmune Retinopathy.
Benson MD; Plemel DJA; Yacyshyn E; Sandhu I; MacDonald IM; Baker CF
Ocul Immunol Inflamm; 2020 Aug; 28(6):958-965. PubMed ID: 31418623
[TBL] [Abstract][Full Text] [Related]
3. Rituximab as a monotherapy or in combination therapy for the treatment of non-paraneoplastic autoimmune retinopathy.
Maleki A; Lamba N; Ma L; Lee S; Schmidt A; Foster CS
Clin Ophthalmol; 2017; 11():377-385. PubMed ID: 28255228
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy.
Boudreault K; Justus S; Sengillo JD; Schuerch K; Lee W; Cabral T; Tsang SH
Orphanet J Rare Dis; 2017 Jul; 12(1):129. PubMed ID: 28709429
[TBL] [Abstract][Full Text] [Related]
5. The role of cystoid macular edema as a marker in the progression of non-paraneoplastic autoimmune retinopathy.
Finn AP; Thomas AS; Stinnett SS; Keenan RT; Grewal DS; Jaffe GJ
Graefes Arch Clin Exp Ophthalmol; 2018 Oct; 256(10):1867-1873. PubMed ID: 30128606
[TBL] [Abstract][Full Text] [Related]
6. Electroretinographic improvement after rituximab therapy in a patient with autoimmune retinopathy.
Uludag G; Onal S; Arf S; Sayman Muslubas I; Selcukbiricik F; Koc Akbay A; Molinas Mandel N
Am J Ophthalmol Case Rep; 2016 Jul; 2():4-7. PubMed ID: 29503888
[TBL] [Abstract][Full Text] [Related]
7. Outcomes in Autoimmune Retinopathy Patients Treated With Rituximab.
Davoudi S; Ebrahimiadib N; Yasa C; Sevgi DD; Roohipoor R; Papavasilieou E; Comander J; Sobrin L
Am J Ophthalmol; 2017 Aug; 180():124-132. PubMed ID: 28483493
[TBL] [Abstract][Full Text] [Related]
8. Non-paraneoplastic autoimmune retinopathy that developed in fellow eye 10 years after onset in first eye: a case report.
Miura G; Baba T; Iwase T; Ohde H; Kanda A; Saito W; Ishida S; Yamamoto S
BMC Ophthalmol; 2020 Apr; 20(1):132. PubMed ID: 32252709
[TBL] [Abstract][Full Text] [Related]
9. Rituximab for autoimmune retinopathy: Results of a Phase I/II clinical trial.
Armbrust KR; Fox AR; Jeffrey BG; Sherry P; Sen HN
Taiwan J Ophthalmol; 2021; 11(1):64-70. PubMed ID: 33767957
[TBL] [Abstract][Full Text] [Related]
10. A comparison of photopic and scotopic electroretinographic changes in early diabetic retinopathy.
Holopigian K; Seiple W; Lorenzo M; Carr R
Invest Ophthalmol Vis Sci; 1992 Sep; 33(10):2773-80. PubMed ID: 1526726
[TBL] [Abstract][Full Text] [Related]
11. Electroretinograms of eyes with Stickler syndrome.
Kondo H; Fujimoto K; Imagawa M; Oku K; Matsushita I; Hayashi T; Nagata T
Doc Ophthalmol; 2020 Jun; 140(3):233-243. PubMed ID: 31781920
[TBL] [Abstract][Full Text] [Related]
12. Functional changes in rod and cone pathways after photoreceptor loss in light-damaged rats.
Takahashi T; Machida S; Masuda T; Mukaida Y; Tazawa Y
Curr Eye Res; 2005 Aug; 30(8):703-13. PubMed ID: 16109651
[TBL] [Abstract][Full Text] [Related]
13. Contribution of voltage-gated sodium channels to the b-wave of the mammalian flash electroretinogram.
Mojumder DK; Sherry DM; Frishman LJ
J Physiol; 2008 May; 586(10):2551-80. PubMed ID: 18388140
[TBL] [Abstract][Full Text] [Related]
14. Non-Paraneoplastic Autoimmune Retinopathy: The First Case Report in Korea.
Choi EY; Kim M; Adamus G; Koh HJ; Lee SC
Yonsei Med J; 2016 Mar; 57(2):527-31. PubMed ID: 26847311
[TBL] [Abstract][Full Text] [Related]
15. Quantitative relationship of the scotopic and photopic ERG to photoreceptor cell loss in light damaged rats.
Sugawara T; Sieving PA; Bush RA
Exp Eye Res; 2000 May; 70(5):693-705. PubMed ID: 10870528
[TBL] [Abstract][Full Text] [Related]
16. Electroretinographic monitoring in birdshot chorioretinopathy.
Sobrin L; Lam BL; Liu M; Feuer WJ; Davis JL
Am J Ophthalmol; 2005 Jul; 140(1):52-64. PubMed ID: 16038651
[TBL] [Abstract][Full Text] [Related]
17. The effect of age on human cone and rod ganzfeld electroretinograms.
Weleber RG
Invest Ophthalmol Vis Sci; 1981 Mar; 20(3):392-9. PubMed ID: 7203883
[TBL] [Abstract][Full Text] [Related]
18. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
19. Management of autoimmune retinopathies with immunosuppression.
Ferreyra HA; Jayasundera T; Khan NW; He S; Lu Y; Heckenlively JR
Arch Ophthalmol; 2009 Apr; 127(4):390-7. PubMed ID: 19365013
[TBL] [Abstract][Full Text] [Related]
20. Full-field electroretinogram in autism spectrum disorder.
Constable PA; Gaigg SB; Bowler DM; Jägle H; Thompson DA
Doc Ophthalmol; 2016 Apr; 132(2):83-99. PubMed ID: 26868825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
